Rapport Therapeutics IPO Price Indicating $18 On 276K Shares; IPO Priced At $17 On 8M Shares
Portfolio Pulse from Benzinga Newsdesk
Rapport Therapeutics has set its IPO price at $17 per share, with 8 million shares being offered. The IPO price indicates a potential value of $18 per share on 276,000 shares.
June 07, 2024 | 2:42 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Rapport Therapeutics has set its IPO price at $17 per share, offering 8 million shares. The indicated value is $18 per share on 276,000 shares.
The IPO pricing at $17 per share with an indicated value of $18 per share suggests strong demand and potential for a positive short-term price movement. The offering of 8 million shares indicates significant market interest.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100